{
  "DOI": "10.1186/s40246-019-0229-z",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-019-0229-z",
  "alternative-id": [
    "229"
  ],
  "article-number": "39",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "17 April 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "31 July 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "27 August 2019"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable for this review."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable for this review."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Krebs",
      "given": "Kristi",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5323-3102",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Milani",
      "given": "Lili",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        8,
        27
      ]
    ],
    "date-time": "2019-08-27T13:03:20Z",
    "timestamp": 1566911000000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        8,
        25
      ]
    ],
    "date-time": "2020-08-25T23:15:33Z",
    "timestamp": 1598397333000
  },
  "funder": [
    {
      "DOI": "10.13039/100010686",
      "award": [
        "692145"
      ],
      "doi-asserted-by": "publisher",
      "name": "H2020 European Institute of Innovation and Technology"
    },
    {
      "DOI": "10.13039/501100002301",
      "award": [
        "PRG184",
        "IUT24-6"
      ],
      "doi-asserted-by": "publisher",
      "name": "Eesti Teadusagentuur"
    },
    {
      "DOI": "10.13039/501100008530",
      "award": [
        "2014-2020.4.01.15-0012"
      ],
      "doi-asserted-by": "publisher",
      "name": "European Regional Development Fund"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        17
      ]
    ],
    "date-time": "2024-04-17T19:51:54Z",
    "timestamp": 1713383514537
  },
  "is-referenced-by-count": 119,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2019,
        8,
        27
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            8,
            27
          ]
        ],
        "date-time": "2019-08-27T00:00:00Z",
        "timestamp": 1566864000000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            8,
            27
          ]
        ],
        "date-time": "2019-08-27T00:00:00Z",
        "timestamp": 1566864000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0229-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-019-0229-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0229-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2019,
        8,
        27
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        8,
        27
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/nature15817",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "343",
      "issue": "7573",
      "journal-title": "Nature",
      "key": "229_CR1",
      "unstructured": "Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–50.",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1146/annurev-pharmtox-010814-124835",
      "author": "HM Dunnenberger",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Annu Rev Pharmacol Toxicol",
      "key": "229_CR2",
      "unstructured": "Dunnenberger HM, et al. Preemptive clinical pharmacogenetics implementation: currentprograms in five United States medical centers. Annu Rev Pharmacol Toxicol. 2015;55:89–106.",
      "volume": "55",
      "year": "2015"
    },
    {
      "key": "229_CR3",
      "unstructured": "The African American Cardiovascular Pharmacogenomics Consortium. [Online]. Available: \n                    https://precisionmedicine4all.com\n                    \n                  ."
    },
    {
      "DOI": "10.1038/clpt.2013.72",
      "author": "O Gottesman",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR4",
      "unstructured": "Gottesman O, et al. The CLIPMERGE PGx program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin Pharmacol Ther. 2013;94(2):214–7.",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.1038/gim.2013.72",
      "author": "O Gottesman",
      "doi-asserted-by": "publisher",
      "first-page": "761",
      "issue": "10",
      "journal-title": "Genet Med",
      "key": "229_CR5",
      "unstructured": "Gottesman O, et al. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med. 2013;15(10):761–71.",
      "volume": "15",
      "year": "2013"
    },
    {
      "key": "229_CR6",
      "unstructured": "Genomic and outcomes database for pharmacogenomics and implementation studies (Go-PGx). [Online]. Available: \n                    https://www.genomecanada.ca/en/genomic-and-outcomes-database-pharmacogenomics-and-implementation-studies-go-pgx\n                    \n                  ."
    },
    {
      "author": "KW Weitzel",
      "first-page": "1",
      "issue": "1",
      "journal-title": "BMC Med Genet",
      "key": "229_CR7",
      "unstructured": "Weitzel KW, et al. The IGNITE network: a model for genomic medicine implementation and research. BMC Med Genet. 2016;9(1):1–13.",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.347",
      "author": "MT Eadon",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR8",
      "unstructured": "Eadon MT, et al. Implementation of a pharmacogenomics consult service to support the INGENIOUS trial. Clin Pharmacol Ther. 2016;100(1):63–6.",
      "volume": "100",
      "year": "2016"
    },
    {
      "DOI": "10.2217/pgs.14.31",
      "author": "K Teng",
      "doi-asserted-by": "publisher",
      "first-page": "587",
      "issue": "5",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR9",
      "unstructured": "Teng K, et al. Institutional profile: Cleveland clinic’s center for personalized healthcare: setting the stage for value-based care. Pharmacogenomics. 2014;15(5):587–91.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.2217/pgs.13.59",
      "author": "JA Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "723",
      "issue": "7",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR10",
      "unstructured": "Johnson JA, et al. Institutional Profile Medinice Programm: clinical implementation of pharmacogenetics. Pharmacogenomics. 2013;14(7):723–6.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ajmg.c.31391",
      "author": "JM Hoffman",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "issue": "1",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "229_CR11",
      "unstructured": "Hoffman JM, et al. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet. 2014;166(1):45–55.",
      "volume": "166",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2013.59",
      "author": "AR Shuldiner",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR12",
      "unstructured": "Shuldiner AR, et al. The pharmacogenomics research network translational pharmacogenetics program: overcoming challenges of real-world implementation. Clin Pharmacol Ther. 2013;94(2):207–10.",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.1038/clpt.2011.371",
      "author": "JM Pulley",
      "doi-asserted-by": "publisher",
      "first-page": "87",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR13",
      "unstructured": "Pulley JM, et al. Operational implementation of prospective genotyping for personalized medicine: the design of the vanderbilt PREDICT project. Clin Pharmacol Ther. 2012;92(1):87–95.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.mayocp.2013.10.021",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "issue": "1",
      "journal-title": "Mayo Clin Proc",
      "key": "229_CR14",
      "unstructured": "Wang L, et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time – using genomic data to individualize treatment protocol. Mayo Clin Proc. 2014;89(1):25–33.",
      "volume": "89",
      "year": "2014"
    },
    {
      "key": "229_CR15",
      "unstructured": "South East Asian Pharmacogenomics Research Networ (SEAPHARM). [Online]. Available: \n                    https://www.ims.riken.jp/english/projects/pj09.php\n                    \n                  ."
    },
    {
      "DOI": "10.1038/clpt.2012.117",
      "author": "PH O’Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "446",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR16",
      "unstructured": "O’Donnell PH, et al. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther. 2012;92(4):446–9.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cpt.602",
      "author": "CH van der Wouden",
      "doi-asserted-by": "publisher",
      "first-page": "341",
      "issue": "3",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR17",
      "unstructured": "van der Wouden CH, et al. Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium. Clin Pharmacol Ther. 2017;101(3):341–58.",
      "volume": "101",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.1048",
      "author": "S Volpi",
      "doi-asserted-by": "publisher",
      "first-page": "778",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR18",
      "unstructured": "Volpi S, et al. Research directions in the clinical implementation of pharmacogenomics: an overview of US programs and projects. Clin Pharmacol Ther. 2018;103(5):778–86.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.xphs.2017.04.051",
      "author": "Michelle E. Klein",
      "doi-asserted-by": "publisher",
      "first-page": "2368",
      "issue": "9",
      "journal-title": "Journal of Pharmaceutical Sciences",
      "key": "229_CR19",
      "unstructured": "Klein ME, Parvez MM, Shin JG. Clinical implementation of pharmacogenomics for personalized precision medicine: barriers and solutions. J Pharm Sci. 2017;106(9):2368–79.",
      "volume": "106",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.350",
      "author": "W Bush",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR20",
      "unstructured": "Bush W, et al. Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network. Clin Pharmacol Ther. 2016;100(2):160–9.",
      "volume": "100",
      "year": "2016"
    },
    {
      "DOI": "10.1038/clpt.2013.229",
      "author": "SL Van Driest",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR21",
      "unstructured": "Van Driest SL, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014;95(4):423–31.",
      "volume": "95",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cpt.630",
      "author": "JA Luzum",
      "doi-asserted-by": "publisher",
      "first-page": "502",
      "issue": "3",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR22",
      "unstructured": "Luzum JA, et al. The pharmacogenomics research network translational pharmacogenetics program: outcomes and metrics of pharmacogenetic implementations across diverse healthcare systems. Clin Pharmacol Ther. 2017;102(3):502–10.",
      "volume": "102",
      "year": "2017"
    },
    {
      "key": "229_CR23",
      "unstructured": "Chan L, Sani LL, Quah CB. Pharmacogenomics pharmacogenomics in Asia : a systematic. Futur Med. 10(2217):2017, 2017–0009."
    },
    {
      "DOI": "10.1002/cpt.743",
      "author": "GP Patrinos",
      "doi-asserted-by": "publisher",
      "first-page": "739",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR24",
      "unstructured": "Patrinos GP, Mitropoulou C. Measuring the value of pharmacogenomics evidence. Clin Pharmacol Ther. 2017;102(5):739–41.",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41436-018-0431-8",
      "doi-asserted-by": "crossref",
      "key": "229_CR25",
      "unstructured": "Smith DM, et al. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genet Med. 2019;0(0)."
    },
    {
      "DOI": "10.2217/pgs-2018-0142",
      "author": "CA Bousman",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "issue": "1",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR26",
      "unstructured": "Bousman CA, Arandjelovic K, Mancuso SG, Eyre HA, Dunlop BW. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics. 2019;20(1):37–47.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.ejca.2015.11.008",
      "author": "CATC Lunenburg",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "Eur J Cancer",
      "key": "229_CR27",
      "unstructured": "Lunenburg CATC, et al. Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time. Eur J Cancer. 2016;54:40–8.",
      "volume": "54",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jama.2017.11469",
      "author": "BF Gage",
      "doi-asserted-by": "publisher",
      "first-page": "1115",
      "issue": "12",
      "journal-title": "JAMA",
      "key": "229_CR28",
      "unstructured": "Gage BF, et al. Effect of genotype-guided warfarin dosing on clinical events and anticoagulation control among patients undergoing hip or knee arthroplasty: the GIFT randomized clinical trial. JAMA. 2017;318(12):1115–24.",
      "volume": "318",
      "year": "2017"
    },
    {
      "author": "JS Saldivar",
      "first-page": "1",
      "journal-title": "Pharmgenomics Pers Med.",
      "key": "229_CR29",
      "unstructured": "Saldivar JS, et al. Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility. Pharmgenomics Pers Med. 2016;9:1–6.",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2015.63.1325",
      "author": "MJ Deenen",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "issue": "3",
      "journal-title": "J Clin Oncol",
      "key": "229_CR30",
      "unstructured": "Deenen MJ, et al. Upfront genotyping of DPYD∗2A to individualize fluoropyrimidine therapy: a safety and cost analysis. J Clin Oncol. 2016;34(3):227–34.",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.2217/pgs.14.167",
      "author": "C Mitropoulou",
      "doi-asserted-by": "publisher",
      "first-page": "137",
      "issue": "2",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR31",
      "unstructured": "Mitropoulou C, et al. Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke. Pharmacogenomics. 2015;16(2):137–48.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1159/000430915",
      "author": "CA Altar",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "issue": "3",
      "journal-title": "Mol Neuropsychiatry",
      "key": "229_CR32",
      "unstructured": "Altar CA, Carhart J, Allen JD, Hall-Flavin D, Winner J, Dechairo B. Clinical utility of combinatorial pharmacogenomics-guided antidepressant therapy: evidence from three clinical studies. Mol Neuropsychiatry. 2015;1(3):145–55.",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.3111/13696998.2015.1110160",
      "author": "D Brixner",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "issue": "3",
      "journal-title": "J Med Econ",
      "key": "229_CR33",
      "unstructured": "Brixner D, et al. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. J Med Econ. 2016;19(3):213–28.",
      "volume": "19",
      "year": "2016"
    },
    {
      "DOI": "10.1185/03007995.2015.1063483",
      "author": "JG Winner",
      "doi-asserted-by": "publisher",
      "first-page": "1633",
      "issue": "9",
      "journal-title": "Curr Med Res Opin",
      "key": "229_CR34",
      "unstructured": "Winner JG, et al. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation. Curr Med Res Opin. 2015;31(9):1633–43.",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1311386",
      "author": "M Pirmohamed",
      "doi-asserted-by": "publisher",
      "first-page": "2294",
      "issue": "24",
      "journal-title": "N Engl J Med",
      "key": "229_CR35",
      "unstructured": "Pirmohamed M, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med. 2013;369(24):2294–303.",
      "volume": "369",
      "year": "2013"
    },
    {
      "DOI": "10.1038/clpt.2012.66",
      "author": "J S Schildcrout",
      "doi-asserted-by": "publisher",
      "first-page": "235",
      "issue": "2",
      "journal-title": "Clinical Pharmacology \u0026 Therapeutics",
      "key": "229_CR36",
      "unstructured": "Schildcrout JS, et al. Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Clin Pharmacol Ther. 2012;92(2):235–42.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1038/tp.2012.99",
      "author": "DK Hall-Flavin",
      "doi-asserted-by": "publisher",
      "first-page": "e172",
      "issue": "10",
      "journal-title": "Transl Psychiatry",
      "key": "229_CR37",
      "unstructured": "Hall-Flavin DK, et al. Using a pharmacogenomic algorithm to guide the treatment of depression. Transl Psychiatry. 2012;2(10):e172–7.",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.jacc.2010.03.009",
      "author": "RS Epstein",
      "doi-asserted-by": "publisher",
      "first-page": "2804",
      "issue": "25",
      "journal-title": "J Am Coll Cardiol",
      "key": "229_CR38",
      "unstructured": "Epstein RS, et al. Warfarin genotyping reduces hospitalization rates. Results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study). J Am Coll Cardiol. 2010;55(25):2804–12.",
      "volume": "55",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cpt.1035",
      "author": "DM Roden",
      "doi-asserted-by": "publisher",
      "first-page": "787",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR39",
      "unstructured": "Roden DM, et al. Benefit of preemptive pharmacogenetic information on clinical outcome. Clin Pharmacol Ther. 2018;103(5):787–94.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.2165/11531860-000000000-00000",
      "author": "WA Prescott",
      "doi-asserted-by": "publisher",
      "first-page": "279",
      "issue": "4",
      "journal-title": "Pharmacoeconomics",
      "key": "229_CR40",
      "unstructured": "Prescott WA, Doloresco F, Brown J, Paladino JA. Cost effectiveness of pharmacogenomics: a critical and systematic review. Pharmacoeconomics. 2010;28(4):279–93.",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1038/tpj.2017.21",
      "author": "M Verbelen",
      "doi-asserted-by": "publisher",
      "first-page": "395",
      "issue": "5",
      "journal-title": "Pharmacogenomics J",
      "key": "229_CR41",
      "unstructured": "Verbelen M, Weale ME, Lewis CM. Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? Pharmacogenomics J. 2017;17(5):395–402.",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.2147/NDT.S145046",
      "author": "A Maciel",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Neuropsychiatr Dis Treat",
      "key": "229_CR42",
      "unstructured": "Maciel A, Cullors A, Lukowiak AA, Garces J. Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings. Neuropsychiatr Dis Treat. 2018;14:225–30.",
      "volume": "14",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jmoldx.2016.01.003",
      "author": "Y Ji",
      "doi-asserted-by": "publisher",
      "first-page": "438",
      "issue": "3",
      "journal-title": "J Mol Diagn",
      "key": "229_CR43",
      "unstructured": "Ji Y, et al. Preemptive pharmacogenomic testing for precision medicine: a comprehensive analysis of five actionable pharmacogenomic genes using next-generation DNA sequencing and a customized CYP2D6 genotyping cascade. J Mol Diagn. 2016;18(3):438–45.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41436-018-0337-5",
      "author": "Sulev Reisberg",
      "doi-asserted-by": "publisher",
      "first-page": "1345",
      "issue": "6",
      "journal-title": "Genetics in Medicine",
      "key": "229_CR44",
      "unstructured": "Reisberg S, et al. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions. Genet Med. 2019;21(6):1345–54.",
      "volume": "21",
      "year": "2018"
    },
    {
      "DOI": "10.1592/phco.28.8.992",
      "author": "FW Frueh",
      "doi-asserted-by": "publisher",
      "first-page": "992",
      "issue": "8",
      "journal-title": "Pharmacotherapy",
      "key": "229_CR45",
      "unstructured": "Frueh FW, et al. Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: prevalence of related drug use. Pharmacotherapy. 2008;28(8):992–8.",
      "volume": "28",
      "year": "2008"
    },
    {
      "DOI": "10.1038/clpt.2011.306",
      "author": "EJ Stanek",
      "doi-asserted-by": "publisher",
      "first-page": "450",
      "issue": "3",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR46",
      "unstructured": "Stanek EJ, et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91(3):450–8.",
      "volume": "91",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs-2016-0138",
      "author": "PC Bank",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "issue": "3",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR47",
      "unstructured": "Bank PC, Swen JJ, Guchelaar HJ. A nationwide survey of pharmacists’ perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations. Pharmacogenomics. 2017;18(3):215–25.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1038/tpj.2015.57",
      "author": "JF Peterson",
      "doi-asserted-by": "publisher",
      "first-page": "393",
      "issue": "4",
      "journal-title": "Pharmacogenomics J",
      "key": "229_CR48",
      "unstructured": "Peterson JF, et al. Attitudes of clinicians following large-scale pharmacogenomics implementation. Pharmacogenomics J. 2016;16(4):393–8.",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s00228-017-2292-5",
      "author": "KS Just",
      "doi-asserted-by": "publisher",
      "first-page": "1247",
      "issue": "10",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "229_CR49",
      "unstructured": "Just KS, Steffens M, Swen JJ, Patrinos GP, Guchelaar HJ, Stingl JC. Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). Eur J Clin Pharmacol. 2017;73(10):1247–52.",
      "volume": "73",
      "year": "2017"
    },
    {
      "DOI": "10.1111/j.1399-0004.2012.01908.x",
      "author": "S Haga",
      "doi-asserted-by": "publisher",
      "first-page": "388",
      "issue": "4",
      "journal-title": "Clin Genet",
      "key": "229_CR50",
      "unstructured": "Haga S, Burke W, Ginsburg G, Mills R, Agans R. Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clin Genet. 2012;82(4):388–94.",
      "volume": "82",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs.12.197",
      "author": "L Robb",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "issue": "2",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR51",
      "unstructured": "Robb L, et al. An evaluation of pharmacists’ expectations towards pharmacogenomics. Pharmacogenomics. 2013;14(2):165–75.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1038/gim.2016.120",
      "author": "PJ Caraballo",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "issue": "4",
      "journal-title": "Genet Med",
      "key": "229_CR52",
      "unstructured": "Caraballo PJ, et al. Multidisciplinary model to implement pharmacogenomics at the point of care. Genet Med. 2017;19(4):421–9.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s12911-017-0480-y",
      "author": "M Hinderer",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "BMC Med Inform Decis Mak",
      "key": "229_CR53",
      "unstructured": "Hinderer M, et al. Integrating clinical decision support systems for pharmacogenomic testing into clinical routine- a scoping review of designs of user-system interactions in recent system development. BMC Med Inform Decis Mak. 2017;17(1):1–14.",
      "volume": "17",
      "year": "2017"
    },
    {
      "author": "TM Herr",
      "first-page": "143",
      "issue": "2018",
      "journal-title": "J Am Med Informatics Assoc",
      "key": "229_CR54",
      "unstructured": "Herr TM, Peterson JF, Rasmussen LV, Caraballo PJ, Peissig PL, Starren JB. Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE Network. J Am Med Informatics Assoc. 2018;26(2018):143–8.",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1093/jamia/ocy005",
      "author": "Kathrin Blagec",
      "doi-asserted-by": "publisher",
      "first-page": "893",
      "issue": "7",
      "journal-title": "Journal of the American Medical Informatics Association",
      "key": "229_CR55",
      "unstructured": "Blagec K, et al. Implementing pharmacogenomics decision support across seven European countries: the Ubiquitous Pharmacogenomics (U-PGx) project. J Am Med Inform Assoc. 2018;25(7):893–8.",
      "volume": "25",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.709",
      "author": "PH O’Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "859",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR56",
      "unstructured": "O’Donnell PH, et al. Pharmacogenomics-based point-of-care clinical decision support significantly alters drug prescribing. Clin Pharmacol Ther. 2017;102(5):859–69.",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.18632/oncotarget.9927",
      "doi-asserted-by": "crossref",
      "key": "229_CR57",
      "unstructured": "Arbitrio M, et al. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine. Oncotarget. 2016;7(33):54028–50."
    },
    {
      "DOI": "10.1002/cpt.280",
      "author": "LV Kalman",
      "doi-asserted-by": "publisher",
      "first-page": "172",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR58",
      "unstructured": "Kalman LV, et al. Pharmacogenetic allele nomenclature: international workgroup recommendations for test result reporting. Clin Pharmacol Ther. 2016;99(2):172–85.",
      "volume": "99",
      "year": "2016"
    },
    {
      "DOI": "10.2353/jmoldx.2010.100090",
      "author": "VM Pratt",
      "doi-asserted-by": "publisher",
      "first-page": "835",
      "issue": "6",
      "journal-title": "J Mol Diagnostics",
      "key": "229_CR59",
      "unstructured": "Pratt VM, et al. Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and association for molecular pathology collaborative project. J Mol Diagnostics. 2010;12(6):835–46.",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s40246-018-0157-3",
      "doi-asserted-by": "crossref",
      "key": "229_CR60",
      "unstructured": "Ingelman-Sundberg M, Mkrtchian S, Zhou Y, Lauschke VM. Integrating rare genetic variants into pharmacogenetic drug response predictions. Hum Genomics. 2018;12(1):26."
    },
    {
      "DOI": "10.1038/tpj.2016.77",
      "author": "GEB Wright",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "issue": "1",
      "journal-title": "Pharmacogenomics J",
      "key": "229_CR61",
      "unstructured": "Wright GEB, Carleton B, Hayden MR, Ross CJD. The global spectrum of protein-coding pharmacogenomic diversity. Pharmacogenomics J. 2018;18(1):187–95.",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ygeno.2018.05.013",
      "author": "Marwa S. Hassan",
      "doi-asserted-by": "publisher",
      "first-page": "869",
      "issue": "4",
      "journal-title": "Genomics",
      "key": "229_CR62",
      "unstructured": "Hassan MS, Shaalan AA, Dessouky MI, Abdelnaiem AE, ElHefnawi M. Evaluation of computational techniques for predicting non-synonymous single nucleotide variants pathogenicity. Genomics. 2019;111(4):869–82.",
      "volume": "111",
      "year": "2019"
    },
    {
      "DOI": "10.2217/pgs-2016-0023",
      "author": "Volker M Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "917",
      "issue": "8",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR63",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M. Requirements for comprehensive pharmacogenetic genotyping platforms. Pharmacogenomics. 2016;17(8):917–24.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41397-018-0044-2",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "issue": "2",
      "journal-title": "Pharmacogenomics J",
      "key": "229_CR64",
      "unstructured": "Zhou Y, Mkrtchian S, Kumondai M, Hiratsuka M, Lauschke VM. An optimized prediction framework to assess the functional impact of pharmacogenetic variants. Pharmacogenomics J. 2019;19(2):115–26.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrg3899",
      "author": "O Shalem",
      "doi-asserted-by": "publisher",
      "first-page": "299",
      "issue": "5",
      "journal-title": "Nat Rev Genet",
      "key": "229_CR65",
      "unstructured": "Shalem O, Sanjana NE, Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet. 2015;16(5):299–311.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41467-018-04252-2",
      "doi-asserted-by": "crossref",
      "key": "229_CR66",
      "unstructured": "Adli M. The CRISPR tool kit for genome editing and beyond. Nat Commun. 2018;9(1):1911."
    },
    {
      "DOI": "10.1097/FPC.0000000000000202",
      "author": "AS Gordon",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "issue": "4",
      "journal-title": "Pharmacogenet Genomics",
      "key": "229_CR67",
      "unstructured": "Gordon AS, Fulton RS, Qin X, Mardis ER, Nickerson DA, Scherer S. PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation. Pharmacogenet Genomics. 2016;26(4):161–8.",
      "volume": "26",
      "year": "2016"
    },
    {
      "DOI": "10.1038/clpt.2014.137",
      "author": "LJ Rasmussen-Torvik",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR68",
      "unstructured": "Rasmussen-Torvik LJ, et al. Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther. 2014;96(4):482–9.",
      "volume": "96",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ejhg.2017.51",
      "author": "M Mitt",
      "doi-asserted-by": "publisher",
      "first-page": "869",
      "issue": "7",
      "journal-title": "Eur J Hum Genet",
      "key": "229_CR69",
      "unstructured": "Mitt M, et al. Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel. Eur J Hum Genet. 2017;25(7):869–76.",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.1049",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR70",
      "unstructured": "Swen JJ, et al. Pharmacogenetic information in clinical guidelines: the European perspective. Clin Pharmacol Ther. 2018;103(5):795–801.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1038/clpt.2011.34",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "662",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR71",
      "unstructured": "Swen JJ, et al. Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther. 2011;89(5):662–73.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1038/clpt.2010.279",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "issue": "3",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR72",
      "unstructured": "Relling MV, Klein TE. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2009;89(3):464–7.",
      "volume": "89",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cpt.762",
      "author": "PCD Bank",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR73",
      "unstructured": "Bank PCD, et al. Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the Dutch pharmacogenetics working group. Clin Pharmacol Ther. 2018;103(4):599–618.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.2174/1389200215666140130124910",
      "author": "K Caudle",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "issue": "2",
      "journal-title": "Curr Drug Metab",
      "key": "229_CR74",
      "unstructured": "Caudle K, et al. Incorporation of pharmacogenomics into routine clinical practice: the clinical pharmacogenetics implementation consortium (CPIC) guideline development process. Curr Drug Metab. 2014;15(2):209–17.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2012.96",
      "author": "M Whirl-Carrillo",
      "doi-asserted-by": "publisher",
      "first-page": "414",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR75",
      "unstructured": "Whirl-Carrillo M, et al. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2012;92(4):414–7.",
      "volume": "92",
      "year": "2012"
    },
    {
      "author": "Julia M. Barbarino",
      "first-page": "e1417",
      "issue": "4",
      "journal-title": "Wiley Interdisciplinary Reviews: Systems Biology and Medicine",
      "key": "229_CR76",
      "unstructured": "Barbarino JM, Whirl-Carrillo M, Altman RB, Klein TE. PharmGKB: a worldwide resource for pharmacogenomic information. Wiley Interdiscip Rev Syst Biol Med. 2018;10(4):e1417.",
      "volume": "10",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nrg3054",
      "author": "SR Browning",
      "doi-asserted-by": "publisher",
      "first-page": "703",
      "issue": "10",
      "journal-title": "Nat Rev Genet",
      "key": "229_CR77",
      "unstructured": "Browning SR, Browning BL. Haplotype phasing: existing methods and new developments. Nat Rev Genet. 2011;12(10):703–14.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pgen.1007308",
      "author": "Y Choi",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "4",
      "journal-title": "PLoS Genet",
      "key": "229_CR78",
      "unstructured": "Choi Y, Chan AP, Kirkness E, Telenti A, Schork NJ. Comparison of phasing strategies for whole human genomes. PLoS Genet. 2018;14(4):1–26.",
      "volume": "14",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S1383-5742(97)00040-9",
      "author": "DFV Lewis",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "issue": "3",
      "journal-title": "Mutat Res",
      "key": "229_CR79",
      "unstructured": "Lewis DFV, Watson E, Lake BG. Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics. Mutat Res. 1998;410(3):245–70.",
      "volume": "410",
      "year": "1998"
    },
    {
      "DOI": "10.1002/cpt.690",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR80",
      "unstructured": "Zhou Y, Ingelman-Sundberg M, Lauschke VM. Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects. Clin Pharmacol Ther. 2017;102(4):688–700.",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs-2017-0033",
      "author": "Yao Yang",
      "doi-asserted-by": "publisher",
      "first-page": "673",
      "issue": "7",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR81",
      "unstructured": "Yang Y, Botton MR, Scott ER, Scott SA. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing. Pharmacogenomics. 2017;18(7):673–85.",
      "volume": "18",
      "year": "2017"
    },
    {
      "key": "229_CR82",
      "unstructured": "NamedAlleleMatcher 101. [Online]. Available: \n                    https://github.com/PharmGKB/PharmCAT/wiki/NamedAlleleMatcher-101\n                    \n                  ."
    },
    {
      "DOI": "10.1002/cpt.928",
      "author": "Teri E. Klein",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "issue": "1",
      "journal-title": "Clinical Pharmacology \u0026 Therapeutics",
      "key": "229_CR83",
      "unstructured": "Klein TE, Ritchie MD. PharmCAT: a pharmacogenomics clinical annotation tool. Clin Pharmacol Ther. 2018;104(1):19–22.",
      "volume": "104",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs-2018-0028",
      "author": "Kelly E Caudle",
      "doi-asserted-by": "publisher",
      "first-page": "847",
      "issue": "10",
      "journal-title": "Pharmacogenomics",
      "key": "229_CR84",
      "unstructured": "Caudle KE, Keeling NJ, Klein TE, Whirl-Carrillo M, Pratt VM, Hoffman JM. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward. Pharmacogenomics. 2018;19(10):847–60.",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1038/sj.clpt.6100284",
      "author": "JD Robarge",
      "doi-asserted-by": "publisher",
      "first-page": "244",
      "issue": "3",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR85",
      "unstructured": "Robarge JD, Li L, Desta Z, Nguyen A, Flockhart DA. The star-allele nomenclature: retooling for translational genomics. Clin Pharmacol Ther. 2007;82(3):244–8.",
      "volume": "82",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.jmoldx.2015.08.005",
      "author": "VM Pratt",
      "doi-asserted-by": "publisher",
      "first-page": "109",
      "issue": "1",
      "journal-title": "J Mol Diagnostics",
      "key": "229_CR86",
      "unstructured": "Pratt VM, et al. Characterization of 137 genomic DNA reference materials for 28 pharmacogenetic genes: a GeT-RM collaborative project. J Mol Diagnostics. 2016;18(1):109–23.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.1275",
      "author": "A Gaedigk",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther",
      "key": "229_CR87",
      "unstructured": "Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Twist GP, Klein TE, Miller NA. The evolution of PharmVar. Clin Pharmacol Ther. 2019;105(1):29–32.",
      "volume": "105",
      "year": "2019"
    }
  ],
  "reference-count": 87,
  "references-count": 87,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-019-0229-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}